Haleon (HLN) Long-Term Debt Repayments (2022 - 2025)

Haleon's (HLN) quarterly Long-Term Debt Repayments came in at -$1.8 billion in Q4 2025, down 495.7% on a QoQ basis from -$304.1 million in Q4 2023.

Haleon (HLN) Long-Term Debt Repayments (2022 - 2025) Analysis & Trends

Haleon (HLN) has 3 years of Long-Term Debt Repayments data on file, last reported at -$1.8 billion in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-156,847.56
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Alkermes	8.02 Bn	7.37 Bn	397.90 Mn	-

Download Data